150 related articles for article (PubMed ID: 21593189)
1. The L-kynurenine signalling pathway in trigeminal pain processing: a potential therapeutic target in migraine?
Guo S; Vecsei L; Ashina M
Cephalalgia; 2011 Jul; 31(9):1029-38. PubMed ID: 21593189
[TBL] [Abstract][Full Text] [Related]
2. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17():47. PubMed ID: 27130315
[TBL] [Abstract][Full Text] [Related]
3. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L
J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309
[TBL] [Abstract][Full Text] [Related]
4. PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system.
Kruse LS; Møller M; Tibaek M; Gammeltoft S; Olesen J; Kruuse C
Brain Res; 2009 Jul; 1281():25-34. PubMed ID: 19445908
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Tryptophan Metabolic Pathways in Migraine-Related Mechanisms.
Körtési T; Spekker E; Vécsei L
Cells; 2022 Nov; 11(23):. PubMed ID: 36497053
[TBL] [Abstract][Full Text] [Related]
6. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
[TBL] [Abstract][Full Text] [Related]
7. l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.
Vámos E; Párdutz A; Varga H; Bohár Z; Tajti J; Fülöp F; Toldi J; Vécsei L
Neuropharmacology; 2009 Sep; 57(4):425-9. PubMed ID: 19580819
[TBL] [Abstract][Full Text] [Related]
8. Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid.
Knyihár-Csillik E; Toldi J; Krisztin-Péva B; Chadaide Z; Németh H; Fenyo R; Vécsei L
Neurosci Lett; 2007 May; 418(2):122-6. PubMed ID: 17382471
[TBL] [Abstract][Full Text] [Related]
9. [New prospects for antipsychotic treatment - the role of the kynurenine pathway].
Karakuła-Juchnowicz H; Flis M; Szymona K; Kuczyńska M; Stelmach E; Kowal-Popczak A
Psychiatr Pol; 2014; 48(6):1167-77. PubMed ID: 25717486
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan Catabolites and Migraine.
Bohár Z; Párdutz Á; Vécsei L
Curr Pharm Des; 2016; 22(8):1013-21. PubMed ID: 26654771
[TBL] [Abstract][Full Text] [Related]
12. Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders.
Fila M; Chojnacki J; Pawlowska E; Szczepanska J; Chojnacki C; Blasiak J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576297
[TBL] [Abstract][Full Text] [Related]
13. [Kynurenine and its metabolites in nervous system diseases].
Vécsei L; Schwab F
Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152
[TBL] [Abstract][Full Text] [Related]
14. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
Ceresoli-Borroni G; Guidetti P; Amori L; Pellicciari R; Schwarcz R
J Neurosci Res; 2007 Mar; 85(4):845-54. PubMed ID: 17279543
[TBL] [Abstract][Full Text] [Related]
15. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Cwik M; Walkup J; Weis S
Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600
[TBL] [Abstract][Full Text] [Related]
16. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
Barry S; Clarke G; Scully P; Dinan TG
J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
[TBL] [Abstract][Full Text] [Related]
17. Ion Channel Disturbances in Migraine Headache: Exploring the Potential Role of the Kynurenine System in the Context of the Trigeminovascular System.
Spekker E; Nagy-Grócz G; Vécsei L
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068897
[TBL] [Abstract][Full Text] [Related]
18. Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives.
Fejes A; Párdutz A; Toldi J; Vécsei L
Curr Neuropharmacol; 2011 Jun; 9(2):376-87. PubMed ID: 22131946
[TBL] [Abstract][Full Text] [Related]
19. Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.
Nagy-Grócz G; Zádor F; Dvorácskó S; Bohár Z; Benyhe S; Tömböly C; Párdutz Á; Vécsei L
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758944
[TBL] [Abstract][Full Text] [Related]
20. Endogenous kynurenines as targets for drug discovery and development.
Stone TW; Darlington LG
Nat Rev Drug Discov; 2002 Aug; 1(8):609-20. PubMed ID: 12402501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
